Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC)

This study has been terminated.
(Slow recruitment in stratum 3: enrolled only 2 instead of 8 pts. within predicted time)
Sponsor:
Information provided by (Responsible Party):
CureVac AG
ClinicalTrials.gov Identifier:
NCT01915524
First received: July 18, 2013
Last updated: August 4, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2016
  Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):